Rudakova, A. V., Meshkov, D. O., & Mishugin, S. V. (2014). Cost-effectiveness of abiraterone treatment in patients with castration-resistant prostate cancer who previously received docetaxel therapy. ABV-press.
Čikaški stil citiranjaRudakova, A. V., D. O. Meshkov, i S. V. Mishugin. Cost-effectiveness of Abiraterone Treatment in Patients With Castration-resistant Prostate Cancer Who Previously Received Docetaxel Therapy. ABV-press, 2014.
MLA način citiranjaRudakova, A. V., D. O. Meshkov, i S. V. Mishugin. Cost-effectiveness of Abiraterone Treatment in Patients With Castration-resistant Prostate Cancer Who Previously Received Docetaxel Therapy. ABV-press, 2014.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.